{"id":"W4296468443","doi":"10.1016/s2152-2650(22)01478-1","title":"HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Refractory (planetary science); Phases of clinical research; Gastroenterology; Population; Adverse effect; Dosing; Surgery; Toxicity; Lymphoma; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001400986,0.0008836653,0.001314395,0.0004012639,0.0003041301,0.0009776442,0.0007395226,0.0007376247,0.003224835],"category_scores_gemma":[0.0006601439,0.0004326508,0.0008991007,0.0003323517,0.0006885966,0.0009813766,0.0003024643,0.00232973,0.0007414967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007802258,"about_ca_system_score_gemma":0.000844368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100952,"about_ca_topic_score_gemma":0.003507811,"domain_scores_codex":[0.999619,0.0001719134,0.00001612342,0.00006464927,0.0000502464,0.00007803198],"domain_scores_gemma":[0.9996075,0.00008299801,0.0000905355,0.00003776101,0.0000257425,0.0001554643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5977117,0.03692696,0.01898473,0.001130387,0.003094479,0.0003653958,0.0005379025,0.00303648,0.08781999,0.0005180081,0.007211883,0.242662],"study_design_scores_gemma":[0.6721402,0.2577023,0.04989007,0.00006899884,0.001757844,0.000895044,0.0001972421,0.003389917,0.00690491,0.0003172579,0.006636478,0.00009972865],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943587,0.002423947,0.0003672559,0.0002213706,0.00004866188,0.0004266289,0.0008416936,0.0001238151,0.001187901],"genre_scores_gemma":[0.9929371,0.001453745,0.001355943,0.0004847666,0.00008404667,0.000404331,0.001933768,0.0000332286,0.001313027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003224835,"threshold_uncertainty_score":0.01078808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05941375971563122,"score_gpt":0.3922615825630272,"score_spread":0.3328478228473959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}